These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 716131)

  • 21. [State of blood coagulation and capillary permeability in patients with lung cancer].
    Kravchenko LF; Topchienko VS
    Ter Arkh; 1976; 40(2):84-7. PubMed ID: 968767
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of autologous blood for elimination of the residual pleural cavity after pneumonectomy].
    Kariev TM; Ibragimov MA
    Vestn Khir Im I I Grek; 1987 Sep; 139(9):33-6. PubMed ID: 3441966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surgical treatment potentials in far-advanced forms of lung cancer].
    Kolesnikov IS; Shalaev SA
    Vestn Khir Im I I Grek; 1982 Jan; 128(1):5-10. PubMed ID: 7064308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase in plasma volume after the transfusion of washed erythrocytes.
    Valeri CR; Donahue K; Feingold HM; Cassidy GP; Altschule MD
    Surg Gynecol Obstet; 1986 Jan; 162(1):30-6. PubMed ID: 3940406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes in the thrombocyte component of hemostasis during the surgical treatment of lung cancer].
    Somonova OV
    Lab Delo; 1986; (7):407-10. PubMed ID: 2429029
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of recombinant human erythropoietin therapy on blood coagulation and fibrinolysis system.
    Kobayashi T; Makuuchi H; Takahashi K; Furuse A; Shibata Y; Tsuno H; Kotsuka Y; Kubota H; Imanaka K; Tsukada T; Nakashima M
    Ann Thorac Cardiovasc Surg; 2001 Oct; 7(5):273-7. PubMed ID: 11743853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemodynamics in double plasmapheresis in lung cancer].
    Zhukov OI; Pleshakov VT; Singaevskiĭ SB
    Vestn Khir Im I I Grek; 1978 Dec; 121(12):96-9. PubMed ID: 741590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preoperative prediction of the loss of lung function due to the surgical treatment for lung cancer].
    Kaneda M; Takeuchi Y; Sakai T; Namikawa S; Yuasa H; Kusagawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Jun; 22(6):468-73. PubMed ID: 6503056
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lung cancer. a. Cardio-pulmonary function in lung cancer and its surgical indications].
    Miyamoto S; Ota M; Abe S
    Kyobu Geka; 1968 Aug; 21(8):546-53. PubMed ID: 5749912
    [No Abstract]   [Full Text] [Related]  

  • 30. [Circulatory disorders in the surgical treatment of lung cancer in persons with ischemic heart disease].
    Shoĭkhet IaN
    Grudn Khir; 1981; (1):62-5. PubMed ID: 7203143
    [No Abstract]   [Full Text] [Related]  

  • 31. Predicted versus observed FEV1 and DLCO after major lung resection: a prospective evaluation at different postoperative periods.
    Brunelli A; Refai M; Salati M; Xiumé F; Sabbatini A
    Ann Thorac Surg; 2007 Mar; 83(3):1134-9. PubMed ID: 17307474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Compensation for bleeding in a surgical milieu. Importance of normovolemic hemodilution. Apropos of 25 cases].
    Gatra A; Mekki-Berrada R; Benaguida M; Akalal L; Mokhtari M; Barrou H; Komiha A
    Acta Chir Belg; 1986; 86(4):231-7. PubMed ID: 3766022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advantages, hazards and prospects of using autologous blood in aortocoronary bypass surgery].
    Dement'eva II
    Anesteziol Reanimatol; 1997; (1):87-90. PubMed ID: 9173834
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of surgery on free-radical reactions in patients with lung cancer].
    Khyshiktuev BS; Khyshiktueva NA; Darenskaia SD
    Vopr Onkol; 1996; 42(6):23-7. PubMed ID: 9123897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk factors in the surgical treatment of patients with lung cancer].
    Kolesnikova RN; Ankudinova SA
    Anesteziol Reanimatol; 2000; (2):4-6. PubMed ID: 10833825
    [No Abstract]   [Full Text] [Related]  

  • 36. Perioperative blood transfusion adversely affects prognosis after resection of Stage I (subset N0) non-oat cell lung cancer.
    Tartter PI; Burrows L; Kirschner P
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):659-62. PubMed ID: 6492836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Changes in blood coagulation physiology of wound blood].
    Trobisch H
    Beitr Infusionsther; 1993; 29():118-25. PubMed ID: 7690644
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of intraoperative cell saver in decreasing postoperative blood transfusions in instrumented posterior lumbar fusion patients.
    Gause PR; Siska PA; Westrick ER; Zavatsky J; Irrgang JJ; Kang JD
    Spine (Phila Pa 1976); 2008 Mar; 33(5):571-5. PubMed ID: 18317204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poor predictive value of hematocrit and hemodynamic parameters for erythrocyte deficits after extensive elective vascular operations.
    Cordts PR; LaMorte WW; Fisher JB; DelGuercio C; Niehoff J; Pivacek LE; Dennis RC; Siebens H; Georgio A; Valeri CR
    Surg Gynecol Obstet; 1992 Sep; 175(3):243-8. PubMed ID: 1514159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of pulmonary function after lobectomy for lung cancer--upper lobectomy might have the same effect as lung volume reduction surgery.
    Kushibe K; Takahama M; Tojo T; Kawaguchi T; Kimura M; Taniguchi S
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):886-90. PubMed ID: 16675249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.